AJU-S56 5%

· AJU Pharm Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AJU-S56 5%, covering 2024-04-08 to 2024-04-08. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of AJU-S56 5% in Dry Eye Syndrome Patients [Phase 3]